Use of antipsychotics among nonagenarian residents in long-term institutional care in Finland

Age and Ageing

Volumn 35, Issue 5, 2006, Pages 508-513

  Alanen, Hanna Mari ^a   Finne Soveri, Harriet ^b   Noro, Anja ^b   Leinonen, Esa ^a,c  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antipsychotic agent; Elderly; Long term institutional care; Minimum Data Set; Nonagenarian

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT;

AGED; ANXIETY DISORDER; ARTICLE; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISRUPTIVE BEHAVIOR; DRUG USE; FEMALE; FINLAND; HUMAN; INSTITUTIONAL CARE; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SOCIAL ADAPTATION; SOCIAL DISABILITY;

AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; ATTITUDE; DRUG UTILIZATION; FEMALE; FINLAND; GERIATRIC ASSESSMENT; HOMES FOR THE AGED; HUMANS; LONG-TERM CARE; MALE; MENTAL DISORDERS; NURSING HOMES;

EID: 33748070225     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afl065     Document Type: Article

References (33)

1. Perls TT, Bochen K, Freeman M et al. Validity of reported age and centenarian prevalence in New England. Age Ageing 1999; 28: 193-7.
2. Kannisto V. Development of Oldest-Old Mortality, 1950-1990: Evidence from 28 Developed Countries. Odense Monographs on Population Aging. Odense: Odense University Press, 1994.
3. STAKES. Statistical Yearbook on Social Welfare and Health Care 2004. http://www.stakes.fi/EN/tilastot/publications/yearbook.htm.
4. STAKES. Care and Services for Older People 2002, Social Security 2003:1. National Research and Development Centre for Welfare and Health (STAKES) Saarijarvi: Gummerus, 2003; 43-48.
5. Oborne CA, Hooper R, Li KC et al. An indicator of appropriate neuroleptic prescribing in nursing homes. Age Ageing 2002; 31: 435-9.
6. Briesacher BA, Limcangco R, Simoni-Wastila L et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005; 165: 1280-5.
7. Margallo-Lana M, Swann A, O'Brien J et al. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry 2001; 16: 39-44.
8. Desai AK. Use of psychopharmacologic agents in the elderly. Clin Geriatr Med 2003; 19: 697-719.
9. Alexopoulos GS, Streim JE, Carpenter D et al. Expert consensus panel for using antipsychotic drugs in older patients. J Clin Psychiatry 2004; 65: 5-99.
10. Lee PE, Gill SS, Freedman M et al. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ 2004; 329: 75.
11. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev 2006; (1): CD003476.
12. http://www.emea.eu.int/htms/human/drugalert/drugalert.htm.
13. http:/Www.fda.gov/cder/drug/infopage/antipsychotics/default.htm.
14. Gill SS, Rochon PA, Herrmann N et al. Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study. BMJ 2005; 330: 445.
15. Morris JN, Hawes C, Murphy K et al. Long-Term Care Resident Assessment Instrument User's Manual Version 2.0. Baltimore, MD: Health Care Financing Administration, 1995.
16. Boholm J. Raisoft software development. In: Noro A et al., eds. Quality and Productivity in Institutional Care for Elderly Residents - Benchmarking with RAI. National Research and Development Centre for Welfare and Health (STAKES) Helsinki: Gummerus, 2005; 39-45.
17. Björkgren MA, Häkkinen U, Finne-Soveri UH et al. Validity and reliability of resource utilization groups (RUG-III) in Finnish long-term care facilities. Scand J Public Health 1999; 27: 228-34.
18. Hawes C, Morris JN, Phillips CD et al. Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS). Gerontologist 1995; 35: 172-8.
19. Morris JN, Fries BE, Mehr DR et al. MDS Cognitive Performance Scale. J Gerontol 1994; 49: M174-82.
20. Hartmaier SL, Sloane PD, Guess HA et al. Validation of the Minimum Data Set Cognitive Performance Scale: Agreement with the Mini-Mental State Examination. J Gerontol A Biol Sci Med Sci 1995; 50: M128-33.
21. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psyciatr Res 1975; 12: 189-98.
22. Burrows AB, Morris JN, Simon SE et al. Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing 2000; 29: 165-72.
23. Casten R, Lawton MP, Pamelee PA et al. Psychometric characteristics of the minimum data set I: Confirmatory factor analysis. J Am Geriatr Soc 1998; 46: 726-35.
24. Lawton MP, Casten R, Pamelee PA et al. Psychometric characteristics of the minimum data set II: Validity. J Am Geriatr Soc 1998; 46: 736-44.
25. Macdonald AJ, Carpenter GI, Box O et al. Dementia and use of psychotropic medication in non-"Elderly Mentally Infirm" nursing homes in South East England. Age Ageing 2002; 31: 58-64.
26. Lindesay J, Matthews R, Jagger C. Factors associated with antipsychotic drug use in residential care: Changes between 1990 and 1997. Int J Geriatr Psychiatry 2003; 18: 511-9.
27. Hosia-Randell H, Pitkälä K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 2005; 22: 793-800.
28. Forsell Y, Winblad B. Psychiatric disturbances and the use of psychotropic drugs in a population of nonagenarians. Int J Geriatr Psychiatry 1997; 12: 533-6.
29. Börjesson-Hanson A, Edin E, Gislason T et al. The prevalence of dementia in 95 year olds. Neurology 2004; 63: 2436-8.
30. Skoog I, Nilsson L, Landahl S et al. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int Psychogeriatr 1993; 5: 33-48.
31. Beekman AT, Bremmer MA, Deeg DJ et al. Anxiety disorders in late life: A report from the longitudinal aging study Amsterdam. Int J Geriatr Psychiatry 1998;13: 717-26.
32. Forsell Y. Predictors for depression, anxiety and psychotic symptoms in a very elderly population: Data from a 3-year follow-up study. Soc Psychiatry Psychiatr Epidemiol 2000; 35: 259-63.
33. Elon R, Pawlson LG. The impact of OBRA on medical practice within nursing facilities. J Am Geriatr Soc 1992; 40: 958-63.